Opyl Limited (ASX:OPL – Get Free Report) insider Antanas (Tony) Guoga purchased 1,500,000 shares of the business’s stock in a transaction dated Wednesday, December 11th. The shares were acquired at an average cost of A$0.03 ($0.02) per share, for a total transaction of A$45,000.00 ($28,662.42).
Opyl Stock Performance
About Opyl
Opyl Limited develops digital tools that enhance healthcare experience for patients in Australia. The company also delivers deep market insights from social media data and enhance clinical research process. It offers Opin, a clinical trial recruitment platform that leverages social media, search engine optimization technologies and emerging artificial intelligence science, and matching patients directly to clinical trials.
Featured Stories
- Five stocks we like better than Opyl
- Are Penny Stocks a Good Fit for Your Portfolio?
- Semtech Stock Climbs as AI Boom Drives Turnaround Success
- P/E Ratio Calculation: How to Assess Stocks
- 3 Companies Leading the Way With Aggressive Stock Buybacks
- Pros And Cons Of Monthly Dividend Stocks
- Is It Time to Buy Nuclear Energy Stocks After the Latest Dip?
Receive News & Ratings for Opyl Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Opyl and related companies with MarketBeat.com's FREE daily email newsletter.
